Jian Liu
31Patents
7h-index
52Co-inventors
72Inventor score
Filing activity: Jul 2, 1993 → Jan 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7442682B2 | Transepithelial delivery of peptides with incretin hormone activities | Human Necessities | 62 | Expired |
| US5472692A | Pro-urokinase mutants | Human Necessities | 20 | Expired |
| US9951149B2 | Reversible heparin molecules and methods of making and using the same | Emerging Cross-Sectional Technologies | 13 | Active |
| US8003621B2 | Drug carriers | Human Necessities | 11 | Active |
| US7531338B2 | Purified and isolated heparan sulfate 3-O-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same | Chemistry; Metallurgy | 10 | Expired |
| US9469851B2 | Recombinant virus products and methods for inhibition of expression of DUX4 | Chemistry; Metallurgy | 7 | Active |
| US8771995B2 | Enzymatic synthesis of sulfated polysaccharides | Chemistry; Metallurgy | 7 | Active |
| US7074401B2 | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots | Human Necessities | 6 | Expired |
| US8309514B2 | Peptide nucleic acid based guanidinium compounds | Human Necessities | 6 | Active |
| US11203772B2 | Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins | Chemistry; Metallurgy | 6 | Active |
| US9133482B2 | Recombinant virus products and methods for inhibition of expression of myotilin | Chemistry; Metallurgy | 4 | Active |
| US11633424B2 | Cell protective methods and compositions | Human Necessities | 4 | Active |
| US7687603B2 | Guanidinium delivery carriers | Chemistry; Metallurgy | 3 | Active |
| US11903963B2 | Short-acting heparin-based anticoagulant compounds and methods | Emerging Cross-Sectional Technologies | 1 | Active |
| US10301649B2 | Recombinant virus products and methods for inhibition of expression of DUX4 | Chemistry; Metallurgy | 1 | Active |
| US11993627B2 | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides | Emerging Cross-Sectional Technologies | 1 | Active |
| US11865137B2 | Sulfated oligosaccharides having anti-inflammatory activity | Human Necessities | 1 | Active |
| US9717752B2 | Uses of antagonists of hyaluronan signaling | Human Necessities | 0 | Active |
| US11701380B2 | Short-acting heparin-based anticoagulant compounds and methods | General | 0 | Revoked |
| US7745392B2 | Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues | Chemistry; Metallurgy | 0 | Active |
| US11851475B2 | Membrane-type metalloprotease inhibitory protein and pharmaceutical and pharmaceutical composition containing same, and respective uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8507646B2 | Treating atherosclerosis | Human Necessities | 0 | Active |
| US8541367B2 | Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof | Physics | 0 | Active |
| US11091760B2 | Recombinant virus products and methods for inhibition of expression of myotilin | Chemistry; Metallurgy | 0 | Active |
| US12325856B2 | Recombinant virus products and methods for inhibition of expression of myotilin | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.